Web Stats Provided By Google Analytics

Friday, March 23, 2018

TherapeuticsMD (TXMD) Stock Rating Reaffirmed by Oppenheimer

... of the company's stock valued at $175,001,000 after purchasing an additional 3,095,804 shares in the last quarter. Ardsley Advisory Partners raised its position in TherapeuticsMD by 4,100.0% during the fourth quarter. Ardsley Advisory Partners now ...
https://www.dailypolitical.com/2018/03/23/therapeuticsmd-txmd-stock-rating-reaffirmed-by-oppenheimer.html

No comments:

Post a Comment

Popular Ardsley Roundup Posts